Alexander Nowak
Stock Analyst at Craig-Hallum
(2.81)
# 1,617
Out of 5,182 analysts
46
Total ratings
47.37%
Success rate
7.11%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BVS Bioventus | Maintains: Buy | $15 → $16 | $8.97 | +78.37% | 7 | Mar 6, 2026 | |
| CELC Celcuity | Maintains: Buy | $96 → $108 | $112.63 | -4.11% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $9.01 | +144.17% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $207.98 | -24.51% | 4 | Nov 13, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $17.25 | +230.43% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $18.31 | -18.08% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $6.48 | +23.46% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.33 | +1,253.38% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $18.61 | +168.67% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $8.31 | +1,825.39% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.80 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $1.87 | +488.24% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $53.13 | +107.04% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $6.90 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $1.32 | +22,627.27% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $9.29 | +201.40% | 1 | Aug 31, 2020 |
Bioventus
Mar 6, 2026
Maintains: Buy
Price Target: $15 → $16
Current: $8.97
Upside: +78.37%
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $112.63
Upside: -4.11%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $9.01
Upside: +144.17%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $207.98
Upside: -24.51%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $17.25
Upside: +230.43%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $18.31
Upside: -18.08%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $6.48
Upside: +23.46%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.33
Upside: +1,253.38%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $18.61
Upside: +168.67%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $8.31
Upside: +1,825.39%
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.80
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $1.87
Upside: +488.24%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $53.13
Upside: +107.04%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $6.90
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $1.32
Upside: +22,627.27%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $9.29
Upside: +201.40%